RegisterLogin

Tofogliflozin

CAT: 0804-HY-14902-01Size: 5 mgDry Ice: NoHazardous: No
CAT#: HY-14902-01Size: 5 mg
Selected
PRICE
AVAILABILITY
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Product image 1
1 / 1
Description
Tofogliflozin (CSG-452) is a highly efficient and selective inhibitor of SGLT2, with Ki values of 2.9, 14.9 and 6.4nM for human, rat and mouse SGLT2 respectively.
CAS Number
[903565-83-3]
Product Name Alternative
CSG452
UNSPSC
12352005
Hazard Statement
H302, H315, H319, H335
Target
SGLT
Type
Reference compound
Related Pathways
Membrane Transporter/Ion Channel
Applications
Metabolism-sugar/lipid metabolism
Field of Research
Metabolic Disease
Assay Protocol
https://www.medchemexpress.com/Tofogliflozin.html
Purity
98.38
Solubility
10 mM in DMSO
Smiles
O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@]21OCC3=CC=C(CC4=CC=C(CC)C=C4)C=C23
Molecular Formula
C22H26O6
Molecular Weight
386.44
Precautions
H302, H315, H319, H335
References & Citations
[1]Nagata T, et al. Tofogliflozin, a novel sodium-glucose co-transporter 2 inhibitor, improves renal and pancreatic function in db/db mice. Br J Pharmacol. 2013 Oct;170 (3) :519-31.|[2]Yamane M, et al. In vitro profiling of the metabolism and drug-drug interaction of tofogliflozin, a potent and highly specific sodium-glucose co-transporter 2 inhibitor, using human liver microsomes, human hepatocytes, and recombinant human CYP. Xenobiotica. 2014 Oct 28:1-9.|[3]Suzuki M, et al. Tofogliflozin, a potent and highly specific sodium/glucose cotransporter 2 inhibitor, improves glycemic control in diabetic rats and mice. J Pharmacol Exp Ther. 2012 Jun;341 (3) :692-701.|[4]Nagata T, et al. Selective SGLT2 inhibition by tofogliflozin reduces renal glucose reabsorption under hyperglycemic but not under hypo- or euglycemic conditions in rats. Am J Physiol Endocrinol Metab. 2013 Feb 15;304 (4) :E414-23.
Shipping Conditions
Room Temperature
Storage Conditions
4°C (Powder, protect from light)
Scientific Category
Reference compound1
Clinical Information
Launched
Isoform
SGLT2
Citation 01
Biochem Pharmacol. 2016 Feb 1:101:27-39.|J Chromatogr B Analyt Technol Biomed Life Sci. 2020 Mar 15;1141:122020.|Biochem Pharmacol. 2018 Jun:152:45-59.|University of Paris. 2022 Sep 19.

Related Products

CatalogName

Alternative Products

CatalogName
M16493-01Tofogliflozin
290198Tofogliflozin
B2083-5Tofogliflozin
T13179-01Tofogliflozin
MBS3606487-01Tofogliflozin
TRC-T528750-25MGTofogliflozin
TRC-T528750-5MGTofogliflozin
B2083-1Tofogliflozin
319803Tofogliflozin
MBS387381-01Tofogliflozin

Popular Products